Skip to main content
SpringerLink
Log in
Book cover

Multidisciplinary Approaches to Common Surgical Problems pp 245–256Cite as

Gastrointestinal Bleeding as a Result of Portal Hypertension

  • Chapter
  • First Online:

  • 535 Accesses

Abstract

TIPS (transjugular intrahepatic portosystemic shunt) was first performed in the early 1980s to treat esophageal varices, but additional indications for the procedure have developed since then. In acute variceal hemorrhage, TIPS is currently implemented in the setting of failed endoscopic intervention and has demonstrated low procedural complication rates, low rebleeding rates, excellent primary patency of the TIPS stent, and low rates of TIPS-induced encephalopathy. Additional techniques have been developed to manage those patients with poor hepatic anatomy and those patients with complicated gastric varices.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol. 2014;31:235–42.

    Article  Google Scholar 

  2. Holland LL, Brooks JP. Toward Rational Fresh Frozen Plasma Transfusion: The effect of plasma transfusion on coagulation test results. American Journal of Clinical Pathology. 2006;126:133–39.

    Google Scholar 

  3. Gaba R. Transjugular intrahepatic portosystemic shunt creation with embolization or obliteration for variceal bleeding. Tech Vasc Interventional Rad. 2016;19:21–35.

    Article  Google Scholar 

  4. Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7(2):141–55.

    Article  CAS  Google Scholar 

  5. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5(3):419–24.

    Article  CAS  Google Scholar 

  6. Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update. J Clin Gastroenterol. 2008;42(5):507–16.

    Article  Google Scholar 

  7. Petersen BD, Clark WI. Direct intracaval portosystemic shunts. Tech Vasc Interv Radiol. 2008;4:230–4.

    Google Scholar 

  8. Alam H, Kim D, Provido H, Kirkpatrick J. Portal vein thrombosis in the adult: surgical implications in an era of dynamic imaging. Am Surg. 1997;63:681–4.

    CAS  PubMed  Google Scholar 

  9. Valla D, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865–71.

    Article  CAS  Google Scholar 

  10. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490–7.

    Article  CAS  Google Scholar 

  11. Janssen HLA. Changing perspectives in portal vein thrombosis. Scand J Gastroenterol. 2000;232(suppl):69–73.

    Google Scholar 

  12. Hollingshead M, et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 2005;16(5):651–61.

    Article  Google Scholar 

  13. Pascal JP, Cales P, Multicentre Study Group. Propranolol in the prevention of first upper gastrointestinal tract haemorrhage in patients with cirrhosis of the liver and oesophageal varices. N Engl J Med. 1987;317:856–61.

    Article  CAS  Google Scholar 

  14. Ideo I, Bellati G, Fesce E, Grimoldi D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective randomised study. Hepatology. 1988;8:6–9.

    Article  CAS  Google Scholar 

  15. Lebrec D, Poynard T, Capron JP, Hillon P, Geoffrey P, Roulot D, Chaput JC, et al. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomised trial. J Hepatol. 1988;7:118–25.

    Article  CAS  Google Scholar 

  16. Italian Multicentre Project for Propranolol in the Prevention of Bleeding. Propranolol prevents first gastrointestinal bleed in non-ascitic cirrhotic patients. Final report of a multicentre randomised trial. J Hepatol. 1989;9:75–83.

    Google Scholar 

  17. Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC, Matloff DS, et al. Propranolol in the prevention of the first haemorrhage from oesophagogastric varices. A multicenter randomised clinical trial. Hepatology. 1991;13:902–12.

    Article  CAS  Google Scholar 

  18. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta analytical review. Hepatology. 1995;22:332–53.

    PubMed  Google Scholar 

  19. Tesdal IK, Filser T, Weiss C, Holm E, Dueber C, Jaschke W. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology. 2005;236(1):360–7.

    Article  Google Scholar 

  20. García-Pagán JC, Caca K, Bureau C, Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–9.

    Article  Google Scholar 

  21. Forauer AR, McLean GK. Transjugular intrahepatic portosystemic shunt constraining stent for the treatment of refractory postprocedural encephalopathy: a simple design utilizing a Palmaz stent and Wallstent. J Vasc Interv Radiol. 1998;9:443–6.

    Article  CAS  Google Scholar 

  22. Pomier-Layrargues G. TIPS and hepatic encephalopathy. Semin Liver Dis. 1996;16:315–20.

    Article  CAS  Google Scholar 

  23. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 1994;20:46–55.

    CAS  PubMed  Google Scholar 

  24. Garcia N Jr, Sanyal AJ. Medical management of complications secondary to portal hypertension. In: Patel NH, Haskal ZJ, Kerlan Jr RK, editors. SCVIR syllabus volume XI: portal hypertension—diagnosis and interventions. 2nd ed. Fairfax: Society of Cardiovascular and Interventional Radiology; 2001. p. 47–62.

    Google Scholar 

  25. Madoff D, Wallace JM, Kamran A, Saxon RR. TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics. 2004;24:21–37.

    Article  Google Scholar 

  26. Van der Rijt CC, Schalm SW, Schat H, et al. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology. 1991;100:1114–8.

    Article  Google Scholar 

  27. Zuckerman DA, Darcy MD, Bocchini TP, Hildebolt CF. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol. 1997;169:1727–31.

    Article  CAS  Google Scholar 

  28. Duan XH, et al. Comparison of Percutaneous Transhepatic Variceal Embolization (PTVE) followed by partial splenic embolization versus ptve alone for the treatment of acute esophagogastric variceal massive hemorrhage. J Vasc Intervent Radiol. 2014;25(12):1858–65.

    Article  Google Scholar 

  29. Xu RY, Liu B, Lin N. Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension. World J Gastroenterol. 2004;10:1072–4.

    Article  Google Scholar 

  30. Saad WE, Lippert A, Saad NE. Ectopic varices: anatomical classification, hemodynamic classification, and hemodynamic-based management. Tech Vasc Interv Radiol. 2013;16(2):108–25.

    Article  Google Scholar 

  31. Kocher N, Tripathy D, McAvoy NC, et al. Bleeding ectopic varices in cirrhosis: the role of transjugular intra-hepatic portosystemic stent shunts. Aliment Pharmacol Ther. 2008;28:294–303.

    Article  Google Scholar 

  32. Hashimoto N, Akhoshi T, Yoshida D, et al. The efficacy of balloon-occluded retrograde transvenous obliteration on small intestinal variceal bleeding. Surgery. 2010;148:145–50.

    Article  Google Scholar 

  33. Vidal V, Joly L, Perreault P, et al. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients. Cardiovasc Intervent Radiol. 2006;29:216–9.

    Article  CAS  Google Scholar 

  34. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. Gastroenterol. 1988;95:434–40.

    Article  CAS  Google Scholar 

  35. Sarin SK, Lahori D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification, and natural history of gastric varices: a long-term follow up study in 568 portal hypertension patients. Hepatology. 1992;16:1343–9.

    Article  CAS  Google Scholar 

  36. Saad WE, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin Intervent Radiol. 2011;28:339–49.

    Article  Google Scholar 

  37. Saad WE. Vascular anatomy and the morphologic and hemodynamic classifications of gastric varices and spontaneous portosystemic shunts relevant to the BRTO procedure. Tech Vasc Interv Radiol. 2013;16:60–100.

    Article  Google Scholar 

  38. Saad WE, Wagner CC, Lippert A, et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol. 2013;108:1612–9.

    Article  Google Scholar 

  39. Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR Am J Roentgenol. 1984;143(3):627–8.

    Article  CAS  Google Scholar 

  40. Kitamoto M, Imamura M, Kamada K, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol. 2002;178(5):1167–74.

    Article  Google Scholar 

  41. Ninoi T, Nakamura K, Kaminou T, et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR Am J Roentgenol. 2004;183(2):369–76.

    Article  Google Scholar 

  42. Ninoi T, Nishida N, Kaminou T, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol. 2005;184(4):1340–6.

    Article  Google Scholar 

  43. Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23(11):1702–9.

    Article  Google Scholar 

  44. Fukuda T, Hirota S, Sugimura K. Long-term results of balloonoccluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12(3):327–36.

    Article  CAS  Google Scholar 

  45. Sonomura T, Sato M, Kishi K, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol. 1998;21(1):27–30.

    Article  CAS  Google Scholar 

  46. Kiyosue H, Matsumoto S, Onishi R, et al. Balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices: therapeutic results and problems [in Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi. 1999;59(1):12–9.

    CAS  PubMed  Google Scholar 

  47. Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol. 1996;167(5):1317–20.

    Article  CAS  Google Scholar 

  48. Chikamori F, Kuniyoshi N, Kawashima T, Takase Y. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roentgenol. 2008;191(2):555–9.

    Article  Google Scholar 

  49. Kumamoto M, Toyonaga A, Inoue H, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol. 2010;25(6):1129–35.

    Article  Google Scholar 

  50. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2001;129(4):414–20.

    Article  CAS  Google Scholar 

  51. Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology. 1999;211(2):349–56.

    Article  CAS  Google Scholar 

  52. Shimoda R, Horiuchi K, Hagiwara S, et al. Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts. Abdom Imaging. 2005;30(3):306–13.

    Article  CAS  Google Scholar 

  53. Takuma Y, Nouso K, Makino Y, Saito S, Shiratori Y. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2005;3(12):1245–52.

    Article  Google Scholar 

  54. Arai H, Abe T, Takagi H, Mori M. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol. 2006;12(24):3866–73.

    Article  Google Scholar 

  55. Arai H, Abe T, Shimoda R, Takagi H, Yamada T, Mori M. Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J Gastroenterol. 2005;40(10):964–71.

    Article  Google Scholar 

  56. Cho SK, Shin SW, Lee IH, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol. 2007;189(6):W365–72.

    Article  Google Scholar 

  57. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Transjugular retrograde obliteration for chronic portosystemic encephalopathy. Abdom Imaging. 2000;25(6):567–71.

    Article  CAS  Google Scholar 

  58. Park KS, Kim YH, Choi JS, et al. Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding [in Korean]. Korean J Gastroenterol. 2006;47(5):370–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Erie County Medical Center, Buffalo, NY, USA

    Jonathan Marshall

Authors
  1. Jonathan Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, Tripler Army Medical Center, Honolulu, HI, USA

    Robert Lim

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Marshall, J. (2019). Gastrointestinal Bleeding as a Result of Portal Hypertension. In: Lim, R. (eds) Multidisciplinary Approaches to Common Surgical Problems. Springer, Cham. https://doi.org/10.1007/978-3-030-12823-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-12823-4_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-12822-7

  • Online ISBN: 978-3-030-12823-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation